MedTrace Logo

Safety/Efficacy Study of Restylane® in Lip Augmentation

NCT00935272 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2012-01-30

Study results available
· View outcomes & findings →

Summary

To determine the safety and effectiveness of Restylane® when used for lip augmentation.

Conditions

  • Lip Augmentation

Interventions

DEVICE

Restylane®

Restylane® injections in the lips

DEVICE

Non-Treatment

Non- Treatment

Sponsors & Collaborators

  • Medicis Global Service Corporation

    lead INDUSTRY

Principal Investigators

  • Heather Corey, MBA · Medicis Global Service Corporation

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2010-06-30
Completion
2010-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00935272 on ClinicalTrials.gov